Document Detail


Reperfusion therapy in acute cerebrovascular syndrome.
MedLine Citation:
PMID:  21102331     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PURPOSE OF REVIEW: Modern reperfusion therapy in acute ischemic stroke therapy is based on an 'as fast as possible' recanalization approach to obtain favorable clinical outcomes. However, arterial recanalization may be achieved without favorable clinical outcome, raising the question of the target population to be treated. We outline key issues that underline acute revascularization therapies.
RECENT FINDINGS: Intravenous (i.v.) thrombolysis remains the gold standard with the benefit of speed but lower recanalization rates of large artery occlusions as compared with intra-arterial routes. Conversely, intra-arterial therapies report higher recanalization rates, but are hampered by procedural delays and risks. Higher rates of recanalization in intra-arterial studies using clot-removal devices have not translated into improved patient functional outcome as compared with i.v. thrombolysis trials. Combined i.v.-intra-arterial therapy hold great promise with both the advantages of i.v. and intra-arterial routes.
SUMMARY: Endovascular therapy is potentially superior to i.v. tissue-type plasminogen activator with the development of new devices, which are now available, but none has been evaluated vs. i.v. thrombolysis. Future developments may include combined strategies or a 'pure' mechanical approach. The critical issue is time-to-reperfusion based on a brain imaging showing salvageable brain tissue with a reduced risk of adverse events associated with reperfusion. Current brain imaging techniques are probably not good enough to discriminate salvageable brain, and parenchymal lesion that may suffer from reperfusion injury.
Authors:
Mikael Mazighi; Pierre Amarenco
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Current opinion in neurology     Volume:  24     ISSN:  1473-6551     ISO Abbreviation:  Curr. Opin. Neurol.     Publication Date:  2011 Feb 
Date Detail:
Created Date:  2010-12-30     Completed Date:  2011-04-14     Revised Date:  2013-01-18    
Medline Journal Info:
Nlm Unique ID:  9319162     Medline TA:  Curr Opin Neurol     Country:  England    
Other Details:
Languages:  eng     Pagination:  59-62     Citation Subset:  IM    
Affiliation:
Neurology and Stroke Departments, Paris 7 Denis Diderot University, Unité INSERM 698: Recherche Clinique en Athérothrombose, Groupe Hospitalier Bichat Claude Bernard, Paris, France. mikael.mazighi@bch.aphp.fr
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Brain Ischemia / therapy
Cerebrovascular Disorders / therapy*
Clinical Trials as Topic
Humans
Reperfusion* / methods
Stroke / therapy
Thrombolytic Therapy
Treatment Outcome

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Possible contributions of lipoproteins and cholesterol to the pathogenesis of diabetes mellitus type...
Next Document:  Oscillopsia: causes and management.